4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Patient-Specific iPSC-Derived Models Link Aberrant Endoplasmic Reticulum Stress Sensing and Response to Juvenile Osteochondritis Dissecans Etiology

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Juvenile osteochondritis dissecans (JOCD) is a pediatric disease, which begins with an osteonecrotic lesion in the secondary ossification center which, over time, results in the separation of the necrotic fragment from the parent bone. JOCD predisposes to early-onset osteoarthritis. However, the knowledge gap in JOCD pathomechanisms severely limits current therapeutic strategies. To elucidate its etiology, we conducted a study with induced pluripotent stem cells (iPSCs) from JOCD and control patients. iPSCs from skin biopsies were differentiated to iMSCs (iPSC-derived mesenchymal stromal cells) and subjected to chondrogenic and endochondral ossification, and endoplasmic reticulum (ER)-stress induction assays. Our study, using 3 JOCD donors, showed that JOCD cells have lower chondrogenic capability and their endochondral ossification process differs from control cells; yet, JOCD- and control-cells accomplish osteogenesis of similar quality. Our findings show that endoplasmic reticulum stress sensing and response mechanisms in JOCD cells, which partially regulate chondrocyte and osteoblast differentiation, are related to these differences. We suggest that JOCD cells are more sensitive to ER stress than control cells, and in pathological microenvironments, such as microtrauma and micro-ischemia, JOCD pathogenesis pathways may be initiated. This study is the first, to the best of our knowledge, to realize the important role that resident cells and their differentiating counterparts play in JOCD and to put forth a novel etiological hypothesis that seeks to consolidate and explain previously postulated hypotheses. Furthermore, our results establish well-characterized JOCD-specific iPSC-derived in vitro models and identified potential targets which could be used to improve diagnostic tools and therapeutic strategies in JOCD.

          Graphical Abstract

          Graphical Abstract

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

          The considerable therapeutic potential of human multipotent mesenchymal stromal cells (MSC) has generated markedly increasing interest in a wide variety of biomedical disciplines. However, investigators report studies of MSC using different methods of isolation and expansion, and different approaches to characterizing the cells. Thus it is increasingly difficult to compare and contrast study outcomes, which hinders progress in the field. To begin to address this issue, the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy proposes minimal criteria to define human MSC. First, MSC must be plastic-adherent when maintained in standard culture conditions. Second, MSC must express CD105, CD73 and CD90, and lack expression of CD45, CD34, CD14 or CD11b, CD79alpha or CD19 and HLA-DR surface molecules. Third, MSC must differentiate to osteoblasts, adipocytes and chondroblasts in vitro. While these criteria will probably require modification as new knowledge unfolds, we believe this minimal set of standard criteria will foster a more uniform characterization of MSC and facilitate the exchange of data among investigators.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response.

            The mammalian unfolded protein response (UPR) protects the cell against the stress of misfolded proteins in the endoplasmic reticulum (ER). We have investigated here the contribution of the UPR transcription factors XBP-1, ATF6alpha, and ATF6beta to UPR target gene expression. Gene profiling of cell lines lacking these factors yielded several XBP-1-dependent UPR target genes, all of which appear to act in the ER. These included the DnaJ/Hsp40-like genes, p58(IPK), ERdj4, and HEDJ, as well as EDEM, protein disulfide isomerase-P5, and ribosome-associated membrane protein 4 (RAMP4), whereas expression of BiP was only modestly dependent on XBP-1. Surprisingly, given previous reports that enforced expression of ATF6alpha induced a subset of UPR target genes, cells deficient in ATF6alpha, ATF6beta, or both had minimal defects in upregulating UPR target genes by gene profiling analysis, suggesting the presence of compensatory mechanism(s) for ATF6 in the UPR. Since cells lacking both XBP-1 and ATF6alpha had significantly impaired induction of select UPR target genes and ERSE reporter activation, XBP-1 and ATF6alpha may serve partially redundant functions. No UPR target genes that required ATF6beta were identified, nor, in contrast to XBP-1 and ATF6alpha, did the activity of the UPRE or ERSE promoters require ATF6beta, suggesting a minor role for it during the UPR. Collectively, these results suggest that the IRE1/XBP-1 pathway is required for efficient protein folding, maturation, and degradation in the ER and imply the existence of subsets of UPR target genes as defined by their dependence on XBP-1. Further, our observations suggest the existence of additional, as-yet-unknown, key regulators of the UPR.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              CHOP is a multifunctional transcription factor in the ER stress response.

              The accumulation of unfolded proteins in the endoplasmic reticulum (ER) induces ER stress. To restore ER homeostasis, cells possess a highly specific ER quality-control system called the unfold protein response (UPR). In the case of prolonged ER stress or UPR malfunction, apoptosis signalling is activated. This ER stress-induced apoptosis has been implicated in the pathogenesis of several conformational diseases. CCAAT-enhancer-binding protein homologous protein (CHOP) is induced by ER stress and mediates apoptosis. Recent studies by the Gotoh group have shown that the CHOP pathway is also involved in ER stress-induced cytokine production in macrophages. The multifunctional roles of CHOP in the ER stress response are discussed below.
                Bookmark

                Author and article information

                Contributors
                Journal
                Stem Cells Transl Med
                Stem Cells Transl Med
                stcltm
                Stem Cells Translational Medicine
                Oxford University Press (US )
                2157-6564
                2157-6580
                May 2023
                17 April 2023
                17 April 2023
                : 12
                : 5
                : 293-306
                Affiliations
                Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University , Atlanta, GA, USA
                Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology , Atlanta, GA, USA
                Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University , Atlanta, GA, USA
                Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology , Atlanta, GA, USA
                George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology , Atlanta, GA, USA
                Regenerative Medicine Institute, National University of Ireland Galway , Galway, Ireland
                Regenerative Medicine Institute, National University of Ireland Galway , Galway, Ireland
                Regenerative Medicine Institute, National University of Ireland Galway , Galway, Ireland
                Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University , Atlanta, GA, USA
                Regenerative Medicine Institute, National University of Ireland Galway , Galway, Ireland
                Regenerative Medicine Institute, National University of Ireland Galway , Galway, Ireland
                Children's Orthopaedics of Atlanta, Children’s Healthcare of Atlanta , Atlanta, GA, USA
                Regenerative Medicine Institute, National University of Ireland Galway , Galway, Ireland
                Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology , Atlanta, GA, USA
                George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology , Atlanta, GA, USA
                Author notes
                Corresponding author: Robert E. Guldberg, PhD, Phil & Penny Knight Campus for Accelerating Scientific Impact, University of Oregon, 6231 University of Oregon, Eugene, OR 97403-6231, USA. Tel: +1 541 346 2120. Email: guldberg@ 123456uoregon.edu
                Corresponding author: Frank Barry, PhD Biomedical Sciences Building, National University of Ireland Galway, Galway H91 W2TY, Ireland. Tel: +353 91 495108. Email: frank.barry@ 123456nuigalway.ie
                Author information
                https://orcid.org/0000-0003-1818-1260
                Article
                szad018
                10.1093/stcltm/szad018
                10184700
                37184892
                7be1f54f-745e-46df-bedf-652a8a24e572
                © The Author(s) 2023. Published by Oxford University Press.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.

                History
                : 12 September 2022
                : 19 January 2023
                Page count
                Pages: 14
                Categories
                Pluripotent Stem Cells
                AcademicSubjects/MED00770
                AcademicSubjects/SCI00960

                induced pluripotent stem cells,articulation disorders,osteochondritis dissecans,osteogenesis,chondrogenesis,endoplasmic reticulum stress

                Comments

                Comment on this article